Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director comp.
Credit agrmnt [a]
Appointed director
CC transcript
Acq. announced
BAXTER INTERNATIONAL INC (BAX) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/27/2023 8-K Quarterly results
Docs: "BAXTER REPORTS SECOND-QUARTER 2023 RESULTS"
07/28/2022 8-K Quarterly results
04/28/2022 8-K Quarterly results
Docs: "BAXTER REPORTS FIRST-QUARTER 2022 RESULTS"
02/17/2022 8-K Quarterly results
Docs: "BAXTER REPORTS FOURTH-QUARTER AND FULL-YEAR 2021 RESULTS"
10/28/2021 8-K Quarterly results
Docs: "BAXTER REPORTS THIRD-QUARTER 2021 RESULTS"
07/29/2021 8-K Quarterly results
Docs: "BAXTER REPORTS SECOND-QUARTER 2021 RESULTS"
02/04/2021 8-K Quarterly results
10/29/2020 8-K Quarterly results
Docs: "BAXTER REPORTS THIRD-QUARTER 2020 RESULTS"
07/30/2020 8-K Quarterly results
04/30/2020 8-K Quarterly results
Docs: "BAXTER REPORTS FIRST-QUARTER 2020 RESULTS"
07/25/2019 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : July 25, 2019 Baxter International Inc. Delaware 1-4448 36-0781620 One Baxter Parkway, Deerfield, Illinois 60015 948-2000 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 under the Exchange ...",
"BAXTER REPORTS SECOND-QUARTER 2019 RESULTS"
04/25/2019 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : April 25, 2019 Baxter International Inc. Delaware 1-4448 36-0781620 One Baxter Parkway, Deerfield, Illinois 60015 948-2000 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 under the Exchange...",
"BAXTER REPORTS FIRST-QUARTER 2019 RESULTS"
01/31/2019 8-K Quarterly results
10/31/2018 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : October 31, 2018 Baxter International Inc. Delaware 1-4448 36-0781620 One Baxter Parkway, Deerfield, Illinois 60015 948-2000 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 under the Exchan...",
"BAXTER REPORTS THIRD-QUARTER 2018 RESULTS AND UPDATES FINANCIAL OUTLOOK FOR FULL-YEAR 2018"
07/26/2018 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : July 26, 2018 Baxter International Inc. Delaware 1-4448 36-0781620 One Baxter Parkway, Deerfield, Illinois 60015 948-2000 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 under the Exchange ...",
"BAXTER REPORTS SECOND-QUARTER 2018 RESULTS AND INCREASES EARNINGS OUTLOOK FOR FULL-YEAR 2018"
04/26/2018 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : April 26, 2018 Baxter International Inc. Delaware 1-4448 36-0781620 One Baxter Parkway, Deerfield, Illinois 60015 948-2000 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 under the Exchange...",
"BAXTER REPORTS FIRST-QUARTER 2018 RESULTS AND INCREASES FINANCIAL OUTLOOK FOR FULL-YEAR 2018"
02/01/2018 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : February 1, 2018 Baxter International Inc. Delaware 1-4448 36-0781620 One Baxter Parkway, Deerfield, Illinois 60015 948-2000 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 under the Exchan...",
"BAXTER REPORTS 2017 FOURTH-QUARTER AND FULL-YEAR RESULTS"
10/25/2017 8-K Quarterly results
07/26/2017 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : July 26, 2017 Baxter International Inc. Delaware 1-4448 36-0781620 One Baxter Parkway, Deerfield, Illinois 60015 948-2000 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 under the Exchange ...",
"BAXTER REPORTS SECOND-QUARTER 2017 RESULTS AND PROVIDES UPDATED FINANCIAL OUTLOOK FOR 2017 AND 2020"
04/26/2017 8-K Form 8-K - Current report
02/01/2017 8-K Form 8-K - Current report
10/25/2016 8-K Form 8-K - Current report
07/26/2016 8-K Form 8-K - Current report
04/26/2016 8-K Quarterly results
Docs: "BAXTER REPORTS FIRST QUARTER 2016 RESULTS AND PROVIDES UPDATED FINANCIAL OUTLOOK FOR FULL-YEAR 2016 Positive Sales Mix and Disciplined Expense Management Contribute to Strong First Quarter Performance Adjusted Earnings Per Share were $0.36; First-quarter GAAP Earnings Per Share were $6.13"
02/02/2016 8-K Quarterly results
Docs: "BAXTER ANNOUNCES FOURTH QUARTER RESULTS AND PROVIDES 2016 FINANCIAL OUTLOOK Post-Spin Margin Expansion Efforts Gain Momentum and Contribute to Strong Fourth Quarter Performance Sales and Earnings Per Share Exceed Guidance for the Quarter"
10/27/2015 8-K Quarterly results
Docs: "BAXTER REPORTS STRONG THIRD QUARTER FINANCIAL RESULTS EXCEEDING PREVIOUSLY ISSUED GUIDANCE Company Well-Positioned to Deliver Solid, Sustained Growth as Leading Medical Products Enterprise Momentum Continues with Clear Focus on Expanding Margins and Value Creation"
07/29/2015 8-K Quarterly results
Docs: "BAXTER REPORTS STRONG SECOND QUARTER FINANCIAL RESULTS EXCEEDING GUIDANCE Company Achieves Significant Milestone with Successful Completion of Baxalta Incorporated Spin-Off, Poised for Profitable Growth"
04/23/2015 8-K Quarterly results
Docs: "BAXTER REPORTS FIRST QUARTER FINANCIAL RESULTS THAT EXCEED GUIDANCE Pipeline Momentum Continues with Achievement of Regulatory Milestones, Regulatory Submissions, and Approvals Company Progresses Toward Mid-Year Separation into Two Independent Companies"
01/29/2015 8-K Quarterly results
Docs: "BAXTER'S FOURTH QUARTER FINANCIAL RESULTS EXCEED EXPECTATIONS Company Achieves Record Sales and Earnings For 2014 Performance Sets Solid Foundation for Planned Separation in Mid-2015"
10/16/2014 8-K Quarterly results
Docs: "BAXTER'S THIRD QUARTER FINANCIAL RESULTS EXCEED GUIDANCE Company Bolsters Portfolio, Achieves Significant Pipeline Milestones and Progresses Toward Separation DEERFIELD, Ill., October 16, 2014 - Baxter International Inc. today posted strong financial results for the third quarter, which exceeded expectations and provided its fourth quarter and full-year 2014 guidance adjusting for the planned divestiture of its vaccines franchise. The company continues to bolster its business portfolios by establishing new collaborations and advancing its new product pipeline with the achievement of significant milestones, and remains on track for the anticipated separation into two independent, leading healthcare companies in mid-2015. For the third quarter, Baxter reported net income of $468 million and ..."
07/17/2014 8-K Quarterly results
Docs: "Amendment No. 1, to the Four-Year Credit Agreement",
"BAXTER EXCEEDS EXPECTATIONS IN SECOND QUARTER WITH STRONG GROWTH ACROSS GLOBAL FRANCHISES Company Confirms Full-Year 2014 Outlook, Narrows EPS Range"
04/17/2014 8-K Quarterly results
Docs: "BAXTER REPORTS STRONG FIRST QUARTER FINANCIAL RESULTS EXCEEDING EXPECTATIONS AND CONFIRMS 2014 FULL-YEAR GUIDANCE Momentum Continues On Advancing New Product Pipeline And Positioning Company for Future Growth"
01/23/2014 8-K Quarterly results
Docs: "BAXTER REPORTS FOURTH QUARTER 2013 FINANCIAL RESULTS IN LINE WITH EXPECTATIONS Sales Growth of 16 Percent Driven by Strong Demand for Hemophilia Therapies, Medical Products & Gambro Acquisition Company Provides 2014 Financial Outlook, Advances New Product Pipeline & Collaborations"
10/17/2013 8-K Quarterly results
Docs: "BAXTER MEETS EXPECTATIONS WITH SOLID FINANCIAL RESULTS FOR THE THIRD QUARTER 2013 Company Further Advances Its Portfolio With Acquisitions and Collaborations, While Achieving New Product Pipeline Milestones DEERFIELD, Ill., October 17, 2013 — Baxter International Inc. today posted solid financial results for the third quarter which met expectations as the company further augmented its portfolio with the acquisition of Gambro AB, and continued to advance its new product pipeline by launching new products, achieving multiple regulatory milestones, and establishing new collaborations. The company also provided guidance for the fourth quarter and confirmed its full-year 2013 financial outlook. For the third quarter, Baxter reported net income of $544 million and earnings per diluted share of $..."
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy